BioStock: Fluicell secures SEK 4 million in directed share issue
Earlier in the month, Fluicell announced raising 4 MSEK through a directed share issue to strengthen the company’s cash position in order to expand its sales operations. The capital raise comes on the heels of a warrant exercise from June, which brought in 26 MSEK before issue costs. All in all, the Swedish biotech company is well set to continue fulfilling its ambitions of helping researchers in the bio and pharma sectors reach new heights.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se